Heparin-Induced Thrombocytopenia in a Nonthrombocytopenic Patient With Toxic Epidermal Necrolysis Causing Fatal Outcome: Is HIT Still a HIT?

被引:1
|
作者
Busche, Marc Nicolai [1 ]
Peters, Tina [1 ]
Knobloch, Karsten [1 ]
Vogt, Peter Maria [1 ]
Rennekampff, Hans-Oliver [1 ]
机构
[1] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-30625 Hannover, Germany
关键词
MOLECULAR-WEIGHT HEPARIN; ARGATROBAN ANTICOAGULATION; UNFRACTIONATED HEPARIN; ANTIBODIES; THROMBOSIS; PLATELET-FACTOR-4; REPLACEMENT; THERAPY; RISK;
D O I
10.1097/BCR.0b013e3181ac05bf
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The definition of heparin-induced thrombocytopenia (HIT) has been modified over time; however, most definitions require a relative or absolute thrombocytopenia after exposure to heparin. Therefore, routine platelet count monitoring has been recommended for screening. We present the case of a 26-year-old male patient with toxic epidermal necrolysis who developed a rapid and fatal clinical presentation of HIT, without thrombocytopenia at the time of diagnosis. Because our patient did not present a relative or absolute thrombocytopenia at the time of serological and clinical confirmation of HIT, routine platelet count monitoring failed to detect HIT in our patient. As a result of the here presented case of rapid and fatal HIT, it may be prudent to consider if thrombocytopenia, although it is still a common and important hallmark of HIT, should be an absolute requirement for the definition of HIT. In cases of HIT without any thrombocytopenia, screening for HIT antibodies may be the only way to detect HIT early enough to react. Because there is a high incidence of HIT antibodies in the general population, which are not always associated with HIT, screening for HIT antibodies cannot be recommended for every patient receiving heparin. However, prospective studies may be useful in determining if routine screening for HIT antibodies can decrease the morbidity and mortality of HIT in critically ill patients receiving therapeutic doses of unfractionated heparin on the intensive care unit. (J Burn Care Res 2009;30: 747-751)
引用
收藏
页码:747 / 751
页数:5
相关论文
共 50 条
  • [21] Acute heparin-induced thrombocytopenia (HIT) without thrombocytopenia post aortocoronary bypass grafting
    Dimitrios, Iliopoulos
    Georgia, Nazou
    Nikolaos, Schizas
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 39 (03) : 289 - 292
  • [22] Successful treatment of heparin-induced thrombocytopenia (HIT) type II in childhood with recombinant hirudin
    Schiffmann, H
    Unterhalt, M
    Harms, K
    Figulla, HR
    Volpel, H
    Greinacher, A
    MONATSSCHRIFT KINDERHEILKUNDE, 1997, 145 (06) : 606 - 612
  • [23] Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors
    Hueser, Norbert
    Assfalg, Volker
    Reim, Daniel
    Novotny, Alexander
    Thorban, Stefan
    Cheng, Zhangjun
    Kornberg, Arno
    Friess, Helmut
    Buechler, Peter
    Matevossian, Edouard
    TRANSPLANT INTERNATIONAL, 2012, 25 (07) : 739 - 747
  • [24] Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT
    Pruthi, R. K.
    Daniels, P. R.
    Nambudiri, G. S.
    Warkentin, T. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) : 499 - 501
  • [25] Management of heparin-induced thrombocytopenia (HIT) in patients with systemic vasculitis and pulmonary haemorrhage
    Thong, Kah Mean
    Toth, Peter
    Khwaja, Arif
    CLINICAL KIDNEY JOURNAL, 2013, 6 (06) : 622 - 625
  • [26] Heparin-induced thrombocytopenia (HIT II) - A drug-associated autoimmune disease
    Nowak, Goetz
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) : 887 - 891
  • [27] Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT)
    Munafo, Nicholas
    Patel, Sagar
    Willett, Kristine C.
    Morrill, Amanda
    CURRENT DRUG THERAPY, 2021, 16 (02) : 126 - 132
  • [28] Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series
    Chieh Min Benjamin Lai
    Tyler Smith
    Agnes Yuet Ying Lee
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 725 - 733
  • [29] Pathomorphological aspects of heparin-induced thrombocytopenia II (HIT-II syndrome)
    B. Hermanns
    U. Janssens
    Stefan Handt
    László Füzesi
    Virchows Archiv, 1998, 432 : 541 - 546
  • [30] Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes
    Prechel, Margaret
    Hudec, Susan
    Lowden, Elizabeth
    Escalante, Vicki
    Emanuele, Nicholas
    Emanuele, Maryann
    Walenga, Jeanine M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 : 294S - 300S